Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 25Genitourinary 23CNS 22Head & Neck 21Thoracic 19Sarcoma 18Breast 14Lymphoid 12Gynecologic 8Other hematologic neoplasm 4Tumor-Agnostic 3Plasma cell 2Other solid neoplasm 2Dermatologic 2NET 1Endocrine 1

Conditions

Sarcoma 2Melanoma 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Ovarian Neoplasms 1Neoplasm Metastasis 1Liposarcoma, Myxoid 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

pembrolizumab 73Nivolumab 60Ipilimumab 38Specimen Handling 30Magnetic Resonance Spectroscopy 26Cyclophosphamide 23Biopsy 19cemiplimab 15Radiosurgery 14relatlimab 12fludarabine 12CTLA-4 Antigen 12binimetinib 11trametinib 9Opdualag 9Immunoglobulin G 9fludarabine phosphate 8avelumab 8Disulfides 8Blood Specimen Collection 8lifileucel 7encorafenib 7dabrafenib 7atezolizumab 7aldesleukin 7Radiotherapy 7Paclitaxel 7X-Rays 6Interleukin-2 6HhAntag691 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Radiation × Dermatologic × 90 days × Clear all
NCT06889766 2026-05-15

LauT1

Centre Hospitalier Universitaire Vaudois

Phase 1 Recruiting
9 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

NCT03132922 2026-05-07

MAGE-A4ᶜ¹º³²T for Multi-Tumor

USWM, LLC (dba US WorldMeds)

Phase 1 Active not recruiting
71 enrolled 20 charts
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡